Jia, Li
- Brigham and Women's Hospital · Surgery (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,925
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#9,925
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Jia, Li as a PI. Multi-PI records show the full award amount for context.
- 1R01CA279410-01R01Contact PIMMS22L loss and PARP inhibition in prostate cancerBrigham and Women's Hospital · Surgery (investigator's affiliation)$409.5Kaward amount
- 5R01CA262524-03R01Contact PIAndrogen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancerBrigham and Women's Hospital · Surgery (investigator's affiliation)$401.3Kaward amount
- 5R21CA267496-02R21Contact PICHEK2 loss promotes prostate cancer resistance to PARP inhibitorsBrigham and Women's Hospital · Surgery (investigator's affiliation)$205Kaward amount
Award organization
Organizations that administered FY2023 awards listing Jia, Li as a PI.
FY2023 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardBrigham and Women's Hospital
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022R01 Grant Holder
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #9925